504 related articles for article (PubMed ID: 24379269)
1. [The role of peroxisome proliferator-activated receptors γ (PPARγ) in obesity and insulin resistance].
Chmielewska-Kassassir M; Woźniak LA; Ogrodniczek P; Wójcik M
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1283-99. PubMed ID: 24379269
[TBL] [Abstract][Full Text] [Related]
2. Monosodium glutamate neonatal intoxication associated with obesity in adult stage is characterized by chronic inflammation and increased mRNA expression of peroxisome proliferator-activated receptors in mice.
Roman-Ramos R; Almanza-Perez JC; Garcia-Macedo R; Blancas-Flores G; Fortis-Barrera A; Jasso EI; Garcia-Lorenzana M; Campos-Sepulveda AE; Cruz M; Alarcon-Aguilar FJ
Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):406-13. PubMed ID: 21205225
[TBL] [Abstract][Full Text] [Related]
3. Daidzein regulates proinflammatory adipokines thereby improving obesity-related inflammation through PPARγ.
Sakamoto Y; Naka A; Ohara N; Kondo K; Iida K
Mol Nutr Food Res; 2014 Apr; 58(4):718-26. PubMed ID: 24343975
[TBL] [Abstract][Full Text] [Related]
4. Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.
Sharma AM; Staels B
J Clin Endocrinol Metab; 2007 Feb; 92(2):386-95. PubMed ID: 17148564
[TBL] [Abstract][Full Text] [Related]
5. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.
Evans JL; Lin JJ; Goldfine ID
Curr Diabetes Rev; 2005 Aug; 1(3):299-307. PubMed ID: 18220606
[TBL] [Abstract][Full Text] [Related]
6. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
Blaschke F; Takata Y; Caglayan E; Law RE; Hsueh WA
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):28-40. PubMed ID: 16239592
[TBL] [Abstract][Full Text] [Related]
7. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319
[TBL] [Abstract][Full Text] [Related]
8. Cyclolepis genistoides D. Don (palo azul) promotes differentiation of adipocytes and regulates adipokine expression.
Sato H; Ishikawa M; Funaki A; Kimura Y; Yoshida H; Fukata H; Hasegawa H; Ueno K
Nutr Res; 2013 Nov; 33(11):922-31. PubMed ID: 24176232
[TBL] [Abstract][Full Text] [Related]
9. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
Tjokroprawiro A
Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma, the ultimate liaison between fat and transcription.
Rocchi S; Auwerx J
Br J Nutr; 2000 Dec; 84 Suppl 2():S223-7. PubMed ID: 11242474
[TBL] [Abstract][Full Text] [Related]
11. Nuclear receptors as targets for drug development: molecular mechanisms for regulation of obesity and insulin resistance by peroxisome proliferator-activated receptor gamma, CREB-binding protein, and adiponectin.
Tsuchida A; Yamauchi T; Kadowaki T
J Pharmacol Sci; 2005 Feb; 97(2):164-70. PubMed ID: 15725703
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma: the more the merrier?
Argmann CA; Cock TA; Auwerx J
Eur J Clin Invest; 2005 Feb; 35(2):82-92; discussion 80. PubMed ID: 15667578
[TBL] [Abstract][Full Text] [Related]
13. Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1).
Medina-Gomez G; Gray S; Vidal-Puig A
Public Health Nutr; 2007 Oct; 10(10A):1132-7. PubMed ID: 17903321
[TBL] [Abstract][Full Text] [Related]
14. Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγ.
Floyd ZE; Stephens JM
Biochim Biophys Acta; 2012 Jul; 1822(7):1090-5. PubMed ID: 22504298
[TBL] [Abstract][Full Text] [Related]
15. Berberine-improved visceral white adipose tissue insulin resistance associated with altered sterol regulatory element-binding proteins, liver x receptors, and peroxisome proliferator-activated receptors transcriptional programs in diabetic hamsters.
Li GS; Liu XH; Zhu H; Huang L; Liu YL; Ma CM; Qin C
Biol Pharm Bull; 2011; 34(5):644-54. PubMed ID: 21532151
[TBL] [Abstract][Full Text] [Related]
16. Obesity, Bioactive Lipids, and Adipose Tissue Inflammation in Insulin Resistance.
Kojta I; Chacińska M; Błachnio-Zabielska A
Nutrients; 2020 May; 12(5):. PubMed ID: 32375231
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas.
Souza-Tavares H; Miranda CS; Vasques-Monteiro IML; Sandoval C; Santana-Oliveira DA; Silva-Veiga FM; Fernandes-da-Silva A; Souza-Mello V
World J Gastroenterol; 2023 Jul; 29(26):4136-4155. PubMed ID: 37475842
[TBL] [Abstract][Full Text] [Related]
18. PPAR gamma gene--a review.
Janani C; Ranjitha Kumari BD
Diabetes Metab Syndr; 2015; 9(1):46-50. PubMed ID: 25450819
[TBL] [Abstract][Full Text] [Related]
19. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
Kravchun P; Kadykova O; Gabisoniia T
Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
[TBL] [Abstract][Full Text] [Related]
20. Natural Peroxisome Proliferator-Activated Receptor γ (PPARγ) Activators for Diabetes.
Abdallah HM; El Dine RS; Mohamed GA; Ibrahim SRM; Shehata IA; El-Halawany AM
Altern Ther Health Med; 2020 Jul; 26(S2):28-44. PubMed ID: 31221946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
